Capital Fund Management S.A. Ligand Pharmaceuticals Inc Put Options Transaction History

Capital Fund Management S.A.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2019 Feb 13, 2020	SELL	$96.94 - $113.59 $358,678 - $420,283	-3,700 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$86.25 - $120.16 $77,625 - $108,144	-900 Reduced 19.57%	3,700 $368,000
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $64,428 - $77,604	-600 Reduced 11.54%	4,600 $525,000
Q1 2019 May 13, 2019	BUY	$105.93 - $142.47 $370,755 - $498,645	3,500 Added 205.88%	5,200 $654,000
Q4 2018 Feb 13, 2019	SELL	$128.36 - $272.13 $975,536 - $2.07 Million	-7,600 Reduced 81.72%	1,700 $231,000
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $696,894 - $905,817	3,300 Added 55.0%	9,300 $2.55 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $904,620 - $1.25 Million	6,000 New	6,000 $1.24 Million

248

17.6M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.